Trial results for a study investigating COVID-19 in cancer center populations were posted on 2025-12-30, detailing confirmed infection rates among 1102 participants.
Background
COVID-19 has presented significant challenges globally, particularly for vulnerable populations such as cancer patients and the healthcare professionals who care for them. Individuals undergoing cancer treatment or in follow-up may have compromised immune systems, potentially increasing their risk of infection and severe disease outcomes. Healthcare staff in cancer centers are also at elevated risk due to their close contact with patients and the nature of their work. Understanding the prevalence and severity of COVID-19 infections within these specific populations is essential for implementing effective protective measures and informing public health strategies.
Trial design
This completed study, designated as Phase NA, enrolled 1102 participants to investigate COVID-19. The trial aimed to constitute a large prospective and longitudinal database of serological data and track infections among three populations: patients undergoing cancer treatment, patients in follow-up, and health personnel within cancer centers. The study did not involve specific interventions but focused on observational data collection.
Key results
The study reported key measurements regarding confirmed COVID-19 infections at 12 months:
- Among cancer center staff, the number of participants with a diagnostic test for SARS-CoV-2 was 55.
- Among cancer patients, the number of participants with a diagnostic test for SARS-CoV-2 was 36.
What this means
The results from this study provide specific counts of confirmed COVID-19 infections among cancer center staff and patients over a 12-month period. These figures underscore the continued presence of SARS-CoV-2 within these vulnerable populations, even as the pandemic evolved. The data can inform ongoing infection control protocols, resource allocation, and targeted protective measures within cancer care settings to safeguard both patients and healthcare workers.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT04421625, titled "Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic", were posted on 2025-12-30 on clinicaltrials.gov.